Should You Avoid Impax Laboratories Inc (IPXL)?
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
Posts Tagged ‘NASDAQ:IPXL’
Why CarMax, Teva Pharmaceuticals And Three Other Stocks Are in Spotlight on Tuesday
Crude prices are 1.5% lower today as traders are taking profits on yesterday's run-up.
Kyle Bass Slashes Portfolio to Short the Yuan
Kyle Bass of Hayman Capital, widely known for betting against subprime mortgages and earning hundreds of millions of dollars from that bet, is making another bold prediction, ...
The Latest Moves by Hedge Funds on 3 Conviction Stocks
Hedge fund vehicles have been underperforming the broader market since 2009, but their investors didn’t necessarily expect them to beat benchmarks.
Do Hedge Funds Love Impax Laboratories Inc (IPXL)?
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings.
New Additions Highlight Kyle Bass’ Top Stock Picks for Q4
Kyle Bass of Hayman Advisors is one investment manager with great cachet, which includes having a chapter dedicated to him in Michael Lewis' post 2007-08 financial crises book...
Why Are These Four Stocks Gaining Ground on Monday?
The major indices have lost over 1% so far on Monday, but several stocks are making big moves in the opposite direction, registering significant gains fueled by positive developments...
Major Insider Activity Spotted At Inovalon Holdings Inc. (INOV), Impax Laboratories Inc. (IPXL), and Integrated Silicon Solution Inc. (ISSI)
Generally, insider buying is believed to suggest management’s confidence in the company and its future outlook, whereas insider selling is usually seen as a bearish sign (however...
Apple (AAPL) Holding Slashed By Giovine Capital But Remains Fund’s Top Pick For Q3
Giovine Capital is a hedge fund that was founded in 1998 by Thomas A. Giovine, who is also the current manager.
Top New Picks of Healthcare Fund Blue Jay Capital: Endo International plc (ENDP), Alkermes Plc (ALKS), Akorn Inc. (AKRX)
Healthcare-focused fund Blue Jay Capital Management, managed by Paul Sinclair, has disclosed its equity portfolio for the reporting period of March 31 in a 13F filed with the ...
Tesoro Corporation (TSO), Walgreens Boots Alliance Inc (WBA), and Impax Laboratories Inc (IPXL): Slate Capital’s Big Payoffs For the First Quarter
David Greenspan's Slate Path Capital staged an impressive performance in the first quarter, according to our metrics, which are based on the fund's equity holdings in companies...
Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?
To the average investor, there are many methods market participants can use to analyze publicly traded companies.
Amgen, Inc. (AMGN), Impax Laboratories Inc (IPXL): Keryx Biopharmaceuticals (KERX)’s Stifel Conference Presentation
There were definitely some good parts in what Keryx Biopharmaceuticals (NASDAQ:KERX) had to say at this week's Stifel Nicolaus Weisel Healthcare Conference in Boston.
This Metric Says You Are Smart to Buy Neurocrine Biosciences, Inc. (NBIX)
In the financial world, there are dozens of indicators investors can use to track publicly traded companies. Two of the best are hedge fund and insider trading movement.
Hedge Funds Are Buying Impax Laboratories Inc (IPXL)
At the moment, there are tons of indicators shareholders can use to analyze publicly traded companies.
Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?
To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies.
Three Things You Need to Know From Keryx Biopharmaceuticals (KERX)’s Q2 Earnings
Keryx Biopharmaceuticals (NASDAQ:KERX) announced its second-quarter results before the market opened on Thursday.
GlaxoSmithKline plc (ADR) (GSK): Does Restless Legs Syndrome Really Shorten Life Span?
It may surprise you, but restless legs syndrome (RLS) affects 7% to 10% of the U.S. population, with varying degrees of severity.
Here is What Hedge Funds Think About Pacira Pharmaceuticals Inc (PCRX)
Is Pacira Pharmaceuticals Inc (NASDAQ:PCRX) a superb investment right now? Hedge funds are in an optimistic mood.
Neurocrine Biosciences, Inc. (NBIX): Are Hedge Funds Right About This Stock?
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 16 hedge funds' portfolio at the end of the first quarter of 2013.
Impax Laboratories Inc (IPXL): Insiders Are Buying, Should You?
In the financial world, there are plenty of metrics market participants can use to track publicly traded companies.
Questcor Pharmaceuticals Inc (QCOR), Impax Laboratories Inc (IPXL): Two Stocks That Double Your Chances For Big Gains
Virtually every investor is quite familiar with the names of big pharmaceutical giants such as GlaxoSmithKline plc (ADR) (NYSE:GSK), Eli Lilly & Co.
Hedge Funds Are Buying Aegerion Pharmaceuticals, Inc. (AEGR)
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds' portfolio at the end of the fourth quarter of 2012.
Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?: Impax Laboratories Inc (IPXL), Pacira Pharmaceuticals Inc (PCRX)
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds' portfolio at the end of December.
Should You Buy Impax Laboratories Inc (NASDAQ:IPXL)?
If you'd ask most shareholders, hedge funds are seen as slow, outdated financial vehicles of yesteryear.
This Week in Biotech: Gilead Sciences, Inc. (GILD), GlaxoSmithKline plc (ADR) (GSK)
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
3 Horrendous Health-Care Stocks This Week: Impax Laboratories Inc (IPXL), Depomed Inc (DEPO), AngioDynamics, Inc. (ANGO)
Mr. Market was a happy camper this week, with the Dow setting all-time highs. However, a few stocks in the health-care sector didn't join the party.
These 3 Stocks Were Sequestered: Impax Laboratories Inc (IPXL), J.C. Penney Company, Inc. (JCP)
Impax Laboratories Inc (IPXL) Whee! Sequestration is fun.
Why Impax Laboratories Inc (IPXL) Shares Cratered
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
